The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation ...